Nvidia eyes a stake in OpenAI ahead of IPO. IPOX® Associate Lukas Muehlbauer highlights the strength of defense listings following York Space Systems’ $4.75 billion debut, though software volatility forces Liftoff Mobile and Visma to delay. Globally, Syngenta targets a $10 billion Hong Kong deal. Meanwhile, IPOX® CEO Josef Schuster warns on celebrity IPOs, and IPOX® VP Kat Liu analyzes tariff risks for Bob’s Discount Furniture.

Belgium’s Agomab Therapeutics debuted on the Nasdaq with a $716 million valuation, despite shares slipping 8% amid a selective market. While biotech activity is rebounding, investor caution remains high for clinical-stage firms. IPOX® Research Associate Lukas Muehlbauer noted that while the window for drugmakers remains open, it is effectively closed for software firms, highlighting a significant divergence in risk appetite across sectors in the current IPO landscape.

Reuters highlights Forgent Power’s successful $8 billion NYSE debut, underscoring the enduring demand for AI infrastructure. IPOX® Research Associate Lukas Muehlbauer provided expert commentary, noting that the midpoint pricing signals "healthy but disciplined investor demand" amid volatility. He emphasized Forgent’s strategic value as a critical infrastructure provider, offering unique exposure to the AI sector distinct from traditional tech firms, driven by surging data center needs.

SpaceX dominates headlines with a potential $1.5 trillion IPO and xAI merger. Defense firm York Space Systems debuts at $4.75 billion, with IPOX® Associate Lukas Muehlbauer noting the sector’s strength. Muehlbauer also analyzes AI infrastructure play Forgent Power and biotech Eikon Therapeutics. IPOX® VP Kat Liu discusses tariff risks for Bob's Discount Furniture, while IPOX® CEO Josef Schuster warns against celebrity-backed listings. Elsewhere, software firm Anaplan preps a return, and JD.com’s property arm files in Hong Kong.

Reuters features IPOX® Associate Lukas Muehlbauer’s commentary on York Space Systems’ $4.75 billion NYSE debut. Muehlbauer notes that the successful listing signals a receptive market for defense and space stocks in 2026, setting the stage for the highly anticipated SpaceX IPO. He also analyzes York’s acquisition of ATLAS Space Operations, cautioning that despite the push into software services, the stock will likely remain volatile and sensitive to government spending news in the near term.

Reuters features IPOX® Research Associate Lukas Muehlbauer’s analysis on Eikon Therapeutics' upcoming $908 million IPO. Muehlbauer highlights the premium placed on CEO Roger Perlmutter’s leadership and the company’s Nobel Prize-backed drug discovery platform. He further contrasts Eikon with recent listings like Aktis Oncology, explaining how Eikon aims to overcome historical toxicity challenges in immune-stimulating drugs. This listing signals renewed momentum for the biotech sector following a challenging 2025.

Bloomberg features IPOX® CEO Josef Schuster’s analysis on the "Once Upon a Farm" IPO, co-founded by Jennifer Garner. Discussing the "Hollywood IPO Curse," Schuster warns that celebrity-backed deals historically underperform, citing an "eight out of 11" failure rate. He urges investors to prioritize operational expertise and management resumes over star power. The article underscores the critical importance of evaluating business fundamentals versus celebrity marketing when assessing new public listings.

Reuters reports that Bob's Discount Furniture is targeting a $2.5 billion valuation in its upcoming NYSE IPO. IPOX® VP Kat Liu analyzed the retailer's position regarding trade risks, noting that the company’s shift away from China sourcing helps mitigate specific tariff concerns. However, Liu cautioned that the stock might still experience volatility driven by broader market sentiment regarding freight costs and global trade, rather than direct margin impacts.

Reuters reports that Forgent Power is targeting an $8.8 billion valuation in its upcoming NYSE debut. IPOX® Associate Lukas Muehlbauer provided expert analysis on the listing, characterizing the company’s heavy focus on data centers as a rare "direct play" on AI spending. Muehlbauer noted that while the growth narrative is strong, the proposed 10x price-to-sales ratio asks investors to pay a significant premium over industry peers.

SpaceX accelerates blockbuster IPO plans by lining up four Wall Street banks, while construction tech firm EquipmentShare hits a $7.2 billion valuation in its Nasdaq debut. IPOX® Associate Lukas Muehlbauer analyzes the deal and crypto custodian BitGo’s volatile start as a 2026 bellwether. The U.S. pipeline grows with filings from prime broker Clear Street and Brazilian fintech Agibank, plus potential moves by Jersey Mike’s and Ledger. Globally, European tank maker KNDS prepares a €25 billion listing, and Alibaba’s chip unit explores a spin-off.

Construction tech firm EquipmentShare surged in its Nasdaq debut, reaching a $7.2 billion valuation. In coverage by Reuters, IPOX® Research Associate Lukas Muehlbauer analyzes the deal, highlighting the company’s tech-driven growth potential against legacy competitors. Muehlbauer also notes the sensitivity of their expansion plans to the interest rate outlook. Read the full update on the latest addition to the U.S. IPO landscape.

IPOX® Associate Lukas Muehlbauer was featured in a recent Reuters article analyzing BitGo’s successful NYSE debut. Muehlbauer notes that BitGo serves as a key bellwether for the 2026 crypto IPO market, launching against the headwinds of a recent sector selloff. He highlights that BitGo’s positioning as a profitable, regulated infrastructure play - rather than a pure token play - helps insulate it from daily Bitcoin volatility.

As the U.S. IPO market heats up in January 2026 with over 20 new listings, Benzinga identifies IPO-focused ETFs as efficient tools for investors. The article highlights the First Trust U.S. Equity Opportunities ETF (FPX) and First Trust International Equity Opportunities ETF (FPXI), both tracking IPOX® indices, as key funds to watch. These strategies offer systematic exposure to the largest U.S. and international IPOs and spin-offs during their critical growth phases.

The U.S. IPO pipeline accelerates as construction tech firm EquipmentShare targets a $6.4 billion valuation, with IPOX® VP Kat Liu highlighting its "narrative premium." Crypto custodian BitGo eyes a $2 billion debut, drawing commentary from IPOX® CEO Josef Schuster and Associate Lukas Muehlbauer on market selectivity. Brazilian fintech Agibank files for a $1 billion listing. Globally, Czech defense giant CSG launches a massive €30 billion IPO, while Chinese chipmaker Montage Technology preps a $22 billion Hong Kong debut.